SARTORIUS (UNSP.ADS)/1/5 (SRT0) - Cash Flow Conversion Efficiency
Based on the latest financial reports, SARTORIUS (UNSP.ADS)/1/5 (SRT0) has a cash flow conversion efficiency ratio of 0.049x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€188.90 Million ≈ $220.84 Million USD) by net assets (€3.89 Billion ≈ $4.55 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
SARTORIUS (UNSP.ADS)/1/5 - Cash Flow Conversion Efficiency Trend (2022–2025)
This chart illustrates how SARTORIUS (UNSP.ADS)/1/5's cash flow conversion efficiency has evolved over time, based on yearly financial data. See SRT0 total equity for net asset value and shareholders' equity analysis.
SARTORIUS (UNSP.ADS)/1/5 Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of SARTORIUS (UNSP.ADS)/1/5 ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Shanghai International Airport Co Ltd
SHG:600009
|
0.041x |
|
MARKS SPENCER ADR LS-25
F:MA6A
|
N/A |
|
Subsea 7 S.A.
OL:SUBC
|
0.066x |
|
Aecom Technology Corporation
NYSE:ACM
|
0.029x |
|
DEUTSCHE WOHNEN ADRS/1/2
F:DWNP
|
0.029x |
|
Dr. Reddy's Laboratories Limited
F:RDDA
|
0.029x |
|
Hainan Airlines Co Ltd A
SHG:600221
|
0.812x |
|
Steel Authority of India Limited
NSE:SAIL
|
0.137x |
Annual Cash Flow Conversion Efficiency for SARTORIUS (UNSP.ADS)/1/5 (2022–2025)
The table below shows the annual cash flow conversion efficiency of SARTORIUS (UNSP.ADS)/1/5 from 2022 to 2025. For the full company profile with market capitalisation and key ratios, see SRT0 stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €3.87 Billion ≈ $4.52 Billion |
€837.00 Million ≈ $978.54 Million |
0.216x | -13.58% |
| 2024-12-31 | €3.90 Billion ≈ $4.56 Billion |
€976.20 Million ≈ $1.14 Billion |
0.250x | -19.08% |
| 2023-12-31 | €2.76 Billion ≈ $3.22 Billion |
€853.60 Million ≈ $997.95 Million |
0.309x | +12.09% |
| 2022-12-31 | €2.66 Billion ≈ $3.11 Billion |
€734.20 Million ≈ $858.36 Million |
0.276x | -- |
About SARTORIUS (UNSP.ADS)/1/5
Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell cult… Read more